Neupulse

Neupulse is a verified spin-out from the University of Nottingham developing a median nerve stimulation wristband for Tourette syndrome. The project has strong scientific backing, successful clinical trials (121 participants), and secured ~$3.2M in seed funding. However, the submission itself contains significant inaccuracies (e.g., claiming 'everyone' as the audience and 'most people have used my product', which is false for a pre-market medical device). The 'marketcap' figure likely refers to valuation. The score reflects high utility and innovation, tempered by the pre-revenue status and low-quality submission data.